Healthcare IT company Novarad is set to be the exclusive distributor of CureMetrix artificial intelligence (AI) mammography software at small and medium-sized imaging centers and hospitals.
Through the agreement, CureMetrix women's health products will be integrated into Novarad's PACS offerings. CureMetrix has developed an AI-based computer-aided detection program called cmAssist, as well as cmDensity, which classifies breast density using American College of Radiology (ACR) BI-RADS standards. Through the tie-up, users will be able to utilize the CureMetrix algorithms on Novarad's NovaMG Pro multimodality workstation.
Through a new partnership, users will be able to utilize AI mammography software developed by CureMetrix on the NovaMG Pro workstation with no need to change equipment. Image courtesy of Novarad.The two companies will also work together on the implementation of CureMetrix's cmAngio AI software, which is designed to assess the risk of coronary heart disease in women undergoing mammography.
